Drug Type Small molecule drug |
Synonyms CBD/CBN, PG-OA-10CN |
Target |
Action agonists |
Mechanism CB agonists(Cannabinoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H30O2 |
InChIKeyQHMBSVQNZZTUGM-ZWKOTPCHSA-N |
CAS Registry13956-29-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis, Knee | Phase 2 | United States | 29 Jul 2021 | |
| Pain | Phase 2 | United States | 29 Jul 2021 |





